6-((CYCLOPROPYLCARBONYL)AMINO)-N-ETHYL-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-3-PYRIDAZINECARBOXAMIDE
UNII B2M3FGX3TQ
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-((cyclopropylcarbonyl)amino)-n-ethyl-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-3-pyridazinecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B2M3FGX3TQ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3030728-54-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H24N8O3 FNUHKCUMSCPTPD-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-((cyclopropylcarbonyl)amino)-n-ethyl-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-3-pyridazinecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.